Intermittent Therapy Increases Risk Of Death From Prostate Cancer
By Dr. Brian McDonough, Medical Editor
PHILADELPHIA (CBS) - It is called intermittent therapy and the technique is very commonly used in the treatment of prostate cancer.
While essentially taking a break from hormone-blocking prostate cancer treatments – once the cancer has stabilized – appears to have short term benefits for erectile function and mental health, it could have a negative effect on survival.
Based on 10 years of follow-up of 1,525 patients, researchers found that patients on intermittent therapy had a 10-20% increase in the risk of death. This raises a crucial issue.
The break certainly is very important but with this knowledge there needs to be a careful look at risks versus benefit. It is an example of how complicated the long-term management of disease can be.